This HTML5 document contains 136 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n11http://dx.doi.org/10.1001/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q38389880
rdf:type
wikibase:Item
schema:description
2016年论文 научни чланак artikel ilmiah bài báo khoa học სამეცნიერო სტატია artículu científicu espublizáu en 2016 научни чланак wissenschaftlicher Artikel 2016年论文 vetenskaplig artikel مقالة علمية نشرت في مايو 2016 מאמר מדעי artikulong pang-agham artículo científico 2016年論文 bilimsel makale 2016年論文 2016년 논문 naučni članak 2016年の論文 articol științific επιστημονικό άρθρο vedecký článok 2016年论文 article científic tieteellinen artikkeli বৈজ্ঞানিক নিবন্ধ научна статия vitenskapelig artikkel 2016年论文 artigo científico บทความทางวิทยาศาสตร์ scientific article published on May 2016 artigo científico article scientific vědecký článek tudományos cikk scienca artikolo 2016年论文 article scientifique scientific article published on May 2016 2016 nî lūn-bûn teaduslik artikkel vitskapeleg artikkel artikull shkencor наукова стаття, опублікована в травні 2016 artykuł naukowy научная статья 2016年論文 2016年論文 мақолаи илмӣ 2016年论文 articolo scientifico artigo científico scientific article published on May 2016 wetenschappelijk artikel videnskabelig artikel 2016年論文
p:P577
wds:Q38389880-B273E2B1-AF4D-49B2-8821-6C75E25BCEB5
wdt:P577
2016-05-01T00:00:00Z
p:P407
wds:Q38389880-DAA2ECA1-567F-41BF-BBCD-6D59170E5AAE
wdt:P407
wd:Q1860
p:P2093
wds:Q38389880-0F1E0830-F745-4C91-A5C0-0748C4962470 wds:Q38389880-23D6D8DD-066A-4219-8E29-79307AB20607 wds:Q38389880-4DE80E8C-A3C5-41CA-8838-B08AD212A9F5 wds:Q38389880-753F74B8-903D-4BEC-BC8B-2905CD28F543 wds:Q38389880-68ADA953-3A66-41BF-B2B7-4BEDE4CCD945 wds:Q38389880-8AF2C554-0716-451C-9C17-8CCD59F445CA wds:Q38389880-92D5D887-AD0F-4FCF-9F49-89E45FB3FA1E wds:Q38389880-AC799A82-EE4C-419E-9B7E-38C996E2693D wds:Q38389880-AD8E179B-D2AF-4A8F-BD31-A1A41A3D6409 wds:Q38389880-B1F14C2A-DFA0-43DE-8265-DBC5156D48D7 wds:Q38389880-F483C2FC-AD0D-4030-AEDC-E13E8CE2B690 wds:Q38389880-E31D0C98-070F-4989-A6A1-08E810EB8309
wdt:P2093
Paul W Armstrong Robert G Josse Joerg Koglin Trial Evaluating Cardiovascular Outcomes With Sitagliptin (TECOS) Study Group M Angelyn Bethel Jyotsna Garg Frans Van de Werf Rury R Holman Jennifer B Green Sigrun Halvorsen Giuseppe Ambrosio John M Lachin
rdfs:label
Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial
skos:prefLabel
Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial
schema:name
Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial
p:P50
wds:Q38389880-409181BD-FE08-4F0A-AF14-A12C3B31F65A wds:Q38389880-5F7234BC-7470-4F93-B863-35C24F2B2445 wds:Q38389880-7CA0CE2C-6FDD-4F01-B16E-97538FB7833C wds:Q38389880-2149D258-2D90-472F-BCF1-5148C039B2A4 wds:Q38389880-23D859A7-B1D5-4C0A-A0C0-065878D70DA3 wds:Q38389880-32F4EE0B-6DBE-4751-80EE-DE4F5102CCC7 wds:Q38389880-B5194622-5645-4FBB-847A-9AD470FFF91E wds:Q38389880-BFA8E4EC-20AB-430E-B09C-8B4F0F918DE4
wdt:P50
wd:Q64350343 wd:Q91960546 wd:Q6224073 wd:Q63021326 wd:Q37382178 wd:Q90099865 wd:Q82040206 wd:Q90906040
p:P1476
wds:Q38389880-E90C3D17-92AA-475C-A25E-0A80E9DE69C4
wdt:P1476
Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial
p:P304
wds:Q38389880-3CAA0A62-7604-4722-9E8A-DC77460FCFCA
wdt:P304
126-135
p:P31
wds:Q38389880-204C2623-E41A-4CA1-BC39-DF984753D218
wdt:P31
wd:Q13442814
p:P921
wds:Q38389880-C4BC0145-4BDB-4C8C-9942-AEAC078008BD wds:Q38389880-94F4508A-D6AA-4E34-ABBF-D2E9443F8D0F wds:Q38389880-A78C7F5C-BD42-45ED-948D-AA43098C3B4E
wdt:P921
wd:Q3025883 wd:Q181754 wd:Q3140971
p:P698
wds:Q38389880-84F315B9-BBF7-4C38-89EB-6AFC5FA6EBEB
wdtn:P698
n12:27437883
wdt:P698
27437883
p:P1433
wds:Q38389880-C5D6A5EC-724B-4385-89E9-ED8BB95DF110
wdt:P1433
wd:Q27727184
p:P433
wds:Q38389880-81342450-7FF7-49F4-93A8-F04949CCB60F
p:P478
wds:Q38389880-96C0759F-CD7A-4D95-ADF6-27DF0AC040C1
wdt:P433
2
wdt:P478
1
p:P356
wds:Q38389880-4CA94DD9-CF0F-48A6-B641-0621B0F90BB0
wdtn:P356
n11:JAMACARDIO.2016.0103
wdt:P356
10.1001/JAMACARDIO.2016.0103